Literature DB >> 7437177

Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study.

S G Haworth, U Sauer, K Bühlmeyer.   

Abstract

The structural effect of prostaglandin E1 on the pulmonary circulation in pulmonary atresia has been studied by applying quantitative morphometric techniques to the injected and inflated lungs of eight babies who had received prostaglandin E1 for between 30 hours and 12 days. The most striking effect was on the pulmonary arterial smooth muscle. Relative arterial medial thickness was reduced and muscle did not extend as far along the arterial pathway as compared with the normal and with untreated cases of pulmonary atresia, dying at a similar age. The reduction in muscularity tended to increase the longer the duration of infusion. In all cases the thin arterial media was less compact than normal, and localised aneurysmal dilatations occurred, varying in extent and severity between cases. The preacinar arteries were dilated in comparison with the untreated cases, but, by contrast, the intra-acinar arteries remained abnormally small. The number of intra-acinar arteries per unit area of lung was greater in prostaglandin E1 treated than in untreated cases. Infusion of prostaglandin E1 is now the ideal emergency treatment for pulmonary atresia, but the findings in the present study suggest that it should be given for as short a time as possible before the pulmonary blood flow is increased by surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437177      PMCID: PMC482280          DOI: 10.1136/hrt.43.3.306

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  29 in total

1.  Association in normal human fibroblasts of elevated levels of adenosine 3':5'-monophosphate with a selective decrease in collagen production.

Authors:  B J Baum; J Moss; S D Breul; R G Crystal
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

2.  Quantitative structural study of pulmonary circulation in the newborn with pulmonary atresia.

Authors:  S G Haworth; L Reid
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

3.  Prostaglandin E-1: a potential mediator of the inflammatory response.

Authors:  G Kaley; R Weiner
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

4.  The response of the ductus arteriosus to prostaglandins.

Authors:  F Coceani; P M Olley
Journal:  Can J Physiol Pharmacol       Date:  1973-03       Impact factor: 2.273

5.  New pathological findings in emphysema of childhood. 1. Polyalveolar lobe with emphysema.

Authors:  A Hislop; L Reid
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

6.  Pulmonary lymph flow and the uptake of liquid from the lungs of the lamb at the start of breathing.

Authors:  P W Humphreys; I C Normand; E O Reynolds; L B Strang
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

7.  Effects of prostaglandins of the E-series on pulmonary and systemic circulations of newborn goats during normoxia and hypoxia.

Authors:  T Tyler; C Leffler; R Wallis; S Cassin
Journal:  Prostaglandins       Date:  1975-12

8.  The effects of prostaglandin E on fetal pulmonary vascular resistance (38588).

Authors:  S Cassin; T Tyler; R Wallis
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

9.  The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.

Authors:  B Meyrick; L Reid
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

10.  Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.

Authors:  A C Gittenberger-de Groot; A J Moulaert; E Harinck; A E Becker
Journal:  Br Heart J       Date:  1978-03
View more
  7 in total

1.  Exercise performance after surgery for pulmonary atresia and intact ventricular septum.

Authors:  Britt-Marie Ekman-Joelsson; Per M Gustafsson; Jan Sunnegårdh
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

2.  Spontaneous dissection of the arterial duct during continuous infusion of prostaglandin E1 in a neonate with aortic arch interruption.

Authors:  Nao Inoue; Satoshi Yasukochi; Kiyohiro Takigiku; Hikoro Matsui; Kohta Takei; Yusuke Nakano; Tessyu Otagiri; Yuichiro Hashida; Yoshifumi Ogiso; Yoshiyuki Maekawa; Kentaro Umezu; Takahiko Sakamoto; Yorikazu Harada
Journal:  J Echocardiogr       Date:  2013-07-31

Review 3.  Pharmacologic manipulation of the ductus arteriosus in the neonate: a physiologic basis and current state of the art.

Authors:  S K Sanyal; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

4.  Pulmonary arterial structure in pulmonary atresia after prostaglandin E2 administration.

Authors:  S G Haworth; E D Silove
Journal:  Br Heart J       Date:  1981-03

5.  Administration of E-type prostaglandins in ductus-dependent congenital heart disease.

Authors:  E D Silove
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

6.  Soft-tissue swelling in two neonates during prostaglandin E1 therapy.

Authors:  S Jureidini; N A Chase; B S Alpert; T Vanderzalm; R E Sheneflet
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

Review 7.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.